Immunotherapy in Lymphoma

Clinical trial NCT06796517 · RECRUITING

Trial details

NCT number: NCT06796517
Sponsor: Sung-Soo Park
Status: RECRUITING
Study type: OBSERVATIONAL

Relapsed/refractory High Grade B Cell Lymphoma High Grade B-cell Lymphoma Diffuse Large B Cell Lymphoma Relapsed Primary Mediastinal Large B-Cell Lymphoma Burkitt Lymphoma

Start date: 2024-06-26
Primary completion: 2025-12-01
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.